- The Washington Times - Wednesday, August 6, 2014

An experimental drug appears to have saved the lives of two Americans hit by the Ebola virus, but President Obama said Wednesday it’s too soon to say whether the treatment should be fast-tracked and exported to Africa.

More than 700 people have died from the Ebola outbreak, which has hit hardest in Guinea, Sierra Leone and Liberia. Two American missionary workers infected while abroad were given the drug ZMapp, which reportedly has helped stop the virus and prevent almost certain death.

Even as African nations struggle to contain the outbreak, Mr. Obama said the U.S. can’t rush the drug onto the global market.


SEE ALSO: Mount Sinai Hospital: ‘Odds are’ patient doesn’t have Ebola


“We’ve got to let the science guide us on this. I don’t think all the information is in on whether this drug is helpful,” he said.

Asked specifically whether the federal government should fast-track its efforts to prove the drug is effective, the president deferred.

“I don’t have enough data right now to offer an opinion on that,” he said.